Xolair
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Evaluation of Xolair® (omalizumab) Therapy in Patients Treated at Orebro University Hospital 2006-2017
LIT.HBPP.V1.2016 © Copyright Bio-Rad Laboratories, Inc. 2016. All rights reserved. Published by Bio-Rad, Endeavour House…
This review focuses on the production, mode of action, possible toxicity, current and future research of xolair as a humanised…
Introduction : The EU label for omalizumab (Xolair) was extended to children This study aimed to investigate changes in quality…
Xolair is a monoclonal antibody that binds the Ce3 domain of IgEs, inducing a conforma-tional change of the immunoglobulin, a…
Current strategies for drug development frequently employ humanization techniques, for example, where a non-human monoclonal…
Anamnese: Diagnostik: Verlauf: History: Diagnostics: Medical Course:
The review of safety of monoclonal anti-ige-antibodies (xolair) — a new medication for the treatment of severe allergic bronchial…
Acquiring Tanox and its asthma franchise gives Genentech an inroad into a new therapeutic area.
lergic rhinitis (SAR) are two of the most prevalent allergic disorders, affecting one of every five Americans. Asthma is an…